Prevention of Radiographic Progression in Higher-Risk Patients with Rheumatoid Arthritis Using Filgotinib in Phase III Studies: Narrative Review of Post Hoc Analyses

Filgotinib is an oral preferential Janus kinase 1 inhibitor that demonstrated significant reductions in radiographic progression, with an acceptable tolerability and safety profile, vs placebo in patients with rheumatoid arthritis (RA) and an inadequate response to methotrexate (MTX-IR; FINCH 1) and...

Descripción completa

Detalles Bibliográficos
Autores principales: Tanaka, Yoshiya, Takeuchi, Tsutomu, Atsumi, Tatsuya, Combe, Bernard G., Aletaha, Daniel, Kaise, Toshihiko, Rajendran, Vijay
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Healthcare 2023
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10654325/
https://www.ncbi.nlm.nih.gov/pubmed/37668865
http://dx.doi.org/10.1007/s40744-023-00590-w

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10654325/
https://www.ncbi.nlm.nih.gov/pubmed/37668865
http://dx.doi.org/10.1007/s40744-023-00590-w

Ejemplares similares